Also, try to avoid intense physical activity for 24 to 48 hours after a dose increase to give your body some time to adjust
With the right guidance and evidence-based treatment, programs like Alan Health can give people the support they need to achieve sustainable, long-term results
not yet FDA-approved for any population Best adult efficacy / 24.2% mean weight loss at 48 weeks (12 mg dose, Phase 2) [1] Adolescent trial data / none published as of May 2026 Primary safety signals in adults / nausea, diarrhea, vomiting, decreased appetite [1] Growth concern / caloric restriction during puberty may slow linear growth velocity Mental-health watch / depression, suicidal ideation screening recommended per FDA adolescent obesity guidance Comparator precedent / semaglutide 2.4 mg studied in STEP TEENS (ages 12, 17) with a similar GI side-effect profile [2] Monitoring minimum / Tanner staging, height velocity, bone-age films, PHQ-A at each visit Why Adolescent Safety Data for Retatrutide Does Not Yet Exist No peer-reviewed trial has enrolled patients aged 12 to 17 for retatrutide as of May 2026
Shortly after Ozempic gained approval, Novo Nordisk conducted a 68-week randomized, double-blind, placebo-controlled trial in participants without type 2 diabetes
Lifting Foundayos launch block, subject to sponsor opt-in, foreshadows formulary strategies for oral GLP-1s expected to expand eligible populations and utilization
They work with your bodys natural processes rather than introducing foreign substances